VALD Secures Significant Growth Equity Investment from FTV Capital

Investment will accelerate geographic expansion and enhance industry-leading product capabilities, cementing VALD's position as a global technology pioneer in musculoskeletal health

VALD, a global health technology company and the system of choice for musculoskeletal ("MSK") health professionals, today announced a significant growth equity investment from FTV Capital, a sector-focused growth equity firm. The investment will enable VALD to grow its global team into new markets, launch new product offerings and capabilities, and continue to utilize AI to create unique applications for the company's industry-leading, proprietary dataset of tens of millions of MSK health records.

MSK health is a historically underserviced and yet vast market. In the U.S. alone, annual spending on MSK services accounts for approximately 12 percent of total healthcare expenditures. The market has been characterized by excessive costs and procedures, inefficient pen-and-paper workflows and poor outcomes. VALD addresses these issues by delivering a comprehensive suite of MSK technologies that enable health, performance and tactical clinicians – ranging from small physical therapy and athletic training practices to large health systems, professional sports teams, leagues and tactical operators – to enhance diagnostic capabilities and capture real-time data, thus driving better outcomes. By assessing strength, balance, movement, speed and more, VALD offers advanced tools that were previously confined to laboratories.

"Over the past decade, we've been able to achieve rapid growth as a first mover in our industry, while the market still remains largely untapped," said Laurie Malone, CEO and co-founder of VALD. "Our fully integrated suite of products, software solutions, and proprietary data empowers our customers to increase efficiencies within their workflows and ultimately improve their standard of care and patient outcomes. FTV brings an unmatched network of investors and advisors, as well as an intimate knowledge of the MSK industry, which are vital to capturing the massive opportunity in front of us and, more importantly, helping millions of patients, athletes, and tactical operators around the world suffering from MSK conditions."

Since its founding in 2015, VALD has demonstrated market-leading growth with revenue more than tripling since 2021, staff in over 30 countries and a dataset of MSK records roughly doubling each year. VALD serves global blue-chip customers including over 75 percent of all major league sports franchises (e.g., NFL, NBA, MLB, NHL and MLS), over 90 percent of Power 5 NCAA colleges, 20 Premier League teams, the U.S. Olympic Team, branches of the U.S. military and thousands of leading health systems and clinics.

"While demand for MSK health services is outpacing other conditions globally, the market is still in the early innings of its digital transformation," said Alex Mason, partner at FTV Capital. "VALD's end-to-end offering is viewed as mission critical by thousands of organizations who rely on its interactive, software-enabled platform to help measure, manage and improve human performance and mobility. We are excited to partner with Laurie and the VALD management team to help usher the company through its next phase of growth and reinforce its dominant position in the market."

As part of this growth investment, Alex Mason and Justin Levine, vice president at FTV Capital, joined VALD's board of directors.

About VALD

VALD is a world leader in musculoskeletal assessment and rehabilitation technologies. VALD technologies are used by thousands of the world's most elite sports organizations, clinics, universities, hospitals and defense departments to measure human movement, performance and injury rehabilitation.

The VALD Suite centers around its software hub, which is populated by data from its ForceDecks Dual Force Plate System, NordBord Hamstring Testing System, ForceFrame Strength Testing System, DynaMo Handheld Strength and ROM, HumanTrak Movement Analysis System, SmartSpeed Timing Gate System, SmartJump Portable Jump Mat and TeleHab Exercise Prescription App.

About FTV Capital

FTV Capital is a sector-focused growth equity investment firm that has raised $6.2 billion to invest in high-growth companies offering a range of innovative solutions in two sectors: enterprise technology and services (which includes a dedicated focus on healthcare) and financial technology and services. FTV's experienced team leverages its domain expertise and proven track record in each of these sectors to help motivated management teams accelerate growth. FTV also provides companies with access to its Global Partner Network®, a group of the world's leading enterprises and executives who have helped FTV portfolio companies for two decades. Founded in 1998, FTV Capital has invested in over 140 portfolio companies, including Agiloft, BillingPlatform, EBANX, Kore.ai, Luma, ReliaQuest, True Potential and Vagaro, and successfully exited/partially exited companies including CardConnect (acquired by First Data), Centaur (acquired by Waystone Group), Egress (acquired by KnowBe4), Enfusion (NYSE:ENFN), Globant (NYSE:GLOB), InvestCloud (recapitalized), Strata Fund Solutions (acquired by Alter Domus), VPay (acquired by Optum) and WorldFirst (acquired by Ant Financial). FTV has offices in San Francisco, New York, Connecticut and London. For more information, please visit www.ftvcapital.com and follow the firm on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240925489242/en/